WITTE OWEN N.

CIK 00017009692 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001700969

Recent Transactions

37 trades

Award
Allogene Therapeutics, Inc.$ALLO
Restricted Stock Unit
2025-06-18+95,400→ 95,400 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to buy)
2024-06-05+191,082→ 191,082 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2023-06-13+74,561→ 292,832 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-08-12$17.25/sh−5,000→ 218,271 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-08-12$17.25/sh−5,000→ 218,271 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-08-11$16.50/sh−10,000→ 223,271 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-08-11$16.50/sh−10,000→ 223,271 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-06-22$11.76/sh−10,000→ 233,271 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2022-06-15+35,535→ 35,535 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-06-15+22,089→ 243,271 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-09-09$25.54/sh−5,000→ 221,182 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-08-20$23.70/sh−5,000→ 231,182 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-08-20$23.24/sh−5,000→ 226,182 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-06-10+28,015→ 28,015 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-06-09$25.05/sh−9,969→ 236,182 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-06-05+9,969→ 246,151 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2019-06-06+26,025→ 26,025 total
Purchase
Allogene Therapeutics, Inc.$ALLO
Common Stock
2018-10-15$18.00/sh+15,000→ 198,750 total
Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2018-10-15+37,432→ 236,182 total
Conversion
Allogene Therapeutics, Inc.$ALLO
Series A Convertible Preferred Stock
2018-10-15−7,130→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Stock Option (Right to Buy)
2017-10-03$96.11/sh−17,130→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Director Stock Option (Right to Buy)
2017-10-03$88.79/sh−8,810→ 0 total
Disposition from Tender
Kite Pharma, Inc.
Common Stock
2017-10-03$180.00/sh−58,535→ 5,715 total
Disposition to Issuer
Kite Pharma, Inc.
Common Stock
2017-10-03−5,715→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Director Stock Option (Right to Buy)
2017-10-03$173.11/sh−10,000→ 0 total
Disposition to Issuer
Kite Pharma, Inc.
Director Stock Option (Right to Buy)
2017-10-03$124.91/sh−30,000→ 0 total
Gift
Kite Pharma, Inc.
Common Stock
2017-09-18−12,000→ 64,250 total
Sale
Kite Pharma, Inc.
Common Stock
2017-06-26$100.60/sh−12,500→ 76,250 total
Exercise/Conversion
Kite Pharma, Inc.
Common Stock
2017-06-23$6.89/sh+10,000→ 98,750 total
Exercise/Conversion
Kite Pharma, Inc.
Employee Stock Option
2017-06-23−2,500→ 0 total
Exercise/Conversion
Kite Pharma, Inc.
Common Stock
2017-06-23$62.44/sh+2,500→ 101,250 total
Sale
Kite Pharma, Inc.
Common Stock
2017-06-23$100.00/sh−12,500→ 88,750 total
Exercise/Conversion
Kite Pharma, Inc.
Employee Stock Option (Right to Buy)
2017-06-23−10,000→ 10,000 total
Award
Kite Pharma, Inc.
Common Stock
2017-06-20+2,410→ 88,750 total
Award
Kite Pharma, Inc.
Director Stock Option (Right to Buy)
2017-06-20+8,810→ 8,810 total
Award
Kite Pharma, Inc.
Common Stock
2017-03-14+4,690→ 86,340 total
Award
Kite Pharma, Inc.
Stock Option (Right to Buy)
2017-03-14+17,130→ 17,130 total

Companies

Recent Filings

Address

210 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov